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Objective:Occlusion of the left atrial appendage is proposed to reduce the risk of stroke
in patients with atrial fibrillation. The third-generation atrial exclusion device, modified
to provide uniform distribution of pressure at appendage exclusion, was assessed for
safety and effectiveness in a canine model and compared with a surgical stapler.
Methods: The atrial exclusion device consists of 2 parallel, straight, rigid titanium
tubes and 2 nitinol springs with a knit-braided polyester fabric. Fourteen mongrel
dogs were implanted with the device at the base of the left atrial appendage via a me-
dian sternotomy. In each dog, the right atrial appendagewas stapled with a commercial
apparatus for comparison. The animals were evaluated at 7 days (n5 3), 30 days (n5
5), and 90 days (n 5 6) after implantation by epicardial echocardiography, left atrial
and coronary angiography, gross pathology, and histology.
Results: Left atrial appendage exclusion was complete and achieved without hemody-
namic instability, and coronary angiography revealed that the left circumflex artery
was patent in all cases. A new endothelial tissue layer developed on the occluded
orifice of the left atrium 90 days after implantation. This endothelial layer was not
evident on the stapled right atrial appendage.
Conclusion: In dogs, the third-generation atrial exclusion device achieved easy, reli-
able, and safe exclusion of the left atrial appendage with favorable histologic results.
Clinical application could provide a new therapeutic option for reducing the risk of
stroke in patients with atrial fibrillation.
T
he left atrial appendage (LAA) is a source of thrombus formation and may con-
tribute to stroke in patients with atrial fibrillation (AF). The presence of AF in-
creases the risk of stroke by 5-fold, and this risk increases with increasing
patient age.1 Anticoagulation therapy with warfarin is one of the most common ther-
apies to prevent strokes, although anticoagulation therapy increases the risks of major
bleeding (2.3% per year) and intracranial hemorrhage (0.9% per year).2 Therefore,
LAA exclusion has been increasingly discussed as a possible alternative for stroke
prevention. Several investigators have reported novel techniques for LAA occlusion
through thoracoscopic or percutaneous approaches.3-7
We previously reported preclinical investigations of a novel device, the atrial ex-
clusion device (AED), which was developed for epicardial LAA exclusion on a beat-
ing or arrested heart.8-10 The first-generation AED has 2 flattened bars made of
stainless steel and covered with braided polyester knit fabrics.9 One of the bars is flex-
ible, and the other is rigid. During studies of this first AED design, the validity of the
AED concept was confirmed. The second-generation AED, composed of 2 curved
parallel and rigid titanium tubes and 2 nitinol springs with knitted-braided polyester
fabric, incorporated modifications to prevent damage to surrounding tissues.8 In the
second-generation AED series, reliable and safe exclusion of the LAA was demon-
strated. Subsequently, the shape of the second-generation AED was modified to im-
prove the quality of LAA occlusion, and the present series, the third-generation AED,
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ETAbbreviations and Acronyms
AED 5 atrial exclusion device
AF 5 atrial fibrillation
ANP 5 atrial natriuretic peptide
BNP 5 brain natriuretic peptide
EE 5 epicardial echocardiography
LAA 5 left atrial appendage
LCX 5 left circumflex artery
RAA 5 right atrial appendage
2D 5 2-dimensional
was designed. The purpose of this study was to evaluate the
third-generation AED by epicardial echocardiography (EE),
left atrial and coronary angiography, gross pathology, and
histology. During evaluation of the third-generation AED,
the right atrial appendage (RAA) was also excluded with
a commercial linear stapling device for comparison with
LAA exclusion achieved via the third-generation AED.
Materials and Methods
Design of the Third-generation Atrial Exclusion
Device
The skeleton of the third-generation AED is composed of 2 parallel,
straight, rigid titanium tubes with elastic nitinol springs arranged at
a 90-degree angle at both ends of the tubes (Figure 1). To ensure that
each segment between the opposing tubes has an equal distribution
of force between them when the AED clips the LAA, the second-
generation AED’s curved titanium tubes have been redesigned
into the straight tubes of the third-generation AED to allow for com-
plete LAA occlusion. The third-generation AED used in this study
was 35mm in length. The rigid titanium tubes are coveredwith a ure-
thane elastomer, and the entire skeleton is covered with a knit-
braided polyester sheath, which promotes rapid ingrowth of fibrous
tissue (Figure 1). The same delivery tool is used to apply to the LAA
as in the previous study.8 The AED can also be easily redeployed if
it is placed at a suboptimal site.
Study Design
A total of 14 mongrel dogs, with a mean weight of 30.9 6 2.8 kg,
were used in the present study. The study was approved by the Cleve-
land Clinic’s Institutional Animal Care and Use Committee, and all
animals received humane care in compliance with the ‘‘Guide for the
Care and Use of Laboratory Animals’’ prepared by the Institute of
Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996.
Atrial Exclusion Device Implantation and Stapling
The dogs were placed under general anesthesia in the supine posi-
tion. The pericardium was opened to expose the LAA and the
RAA via a median sternotomy. A single Millar catheter (SPC350,
Millar Instruments, Houston, Tex) was inserted in the left pul-
monary vein to monitor the left atrial pressure, and a 14-gauge
angiocatheter was placed into the pulmonary vein for left atrial an-
giography. The AED was delivered over the LAA and placed at the1020 The Journal of Thoracic and Cardiovascular Surgery c Obase of the LAA using the same delivery tool that had been used in
the previous studies.8 After the LAA was clamped, the RAA was
stapled with a commercial apparatus (AutoSuture DST Series
TA30: United States Surgical, Norwalk, Conn) to obtain a histologic
comparison with the LAA occlusion via the AED.
Hemodynamic parameters consisting of arterial pressure, left
atrial pressure, and heart rate were collected before (pre-LAA occlu-
sion) and after implantation (post-LAA occlusion). Ventilatory
support was transiently halted while data were acquired. Hemody-
namic parameters were digitized in real time at a sampling rate of
200 Hz with a data-acquisition system (PowerLab, ADInstruments,
Inc, Mountain View, Calif) and stored on a hard disk for subsequent
analyses by a custom-made visual basic program on Excel software
(Excel 2000, Microsoft Corp, Redmond, Wash). Two-dimensional
(2D) EE and Doppler echocardiography were performed on the
open chest before and after implantation. The left atrial volume
was also assessed through a biplane area-length method from the
apical 4- and 2-chamber views. The left ventricular end-diastolic
volume (EDV) and end-systolic volume (ESV) were measured by
single-plane Simpson’s rule. Left ventricular ejection fraction was
calculated by the equation 1003 (EDV – ESV)/EDV. The left ven-
tricular stroke volume was calculated as the difference of EDV mi-
nus ESV. Data acquisition was performed as described in our
previous report.8 Left atrial and left circumflex artery (LCX) angiog-
raphies were performed in the 60-degree left anterior oblique and
30-degree right anterior oblique planes both before and after AED
application.
Figure 1. Skeleton of the AED. A, Two parallel, straight, rigid tita-
nium tubes with elastic nitinol springs and a 90-degree angle at
both ends of the tubes. B, The 2 straight tubes are covered with
urethane elastomer. C, The whole skeleton is covered with
a knit-braided polyester sheath. AED, Atrial exclusion device
(third generation).ctober 2008
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of hemostasis. The dogs were carefully monitored for 7 days (n 5
3), 30 days (n 5 5), or 90 days (n 5 6) in regular housing. Postop-
erative analgesics and antibiotics were administered; however, no
anticoagulants or antiplatelet drugs were given during the postoper-
ative period as a postoperative management.
Terminal Study
At study termination, the dogs were placed in the supine position un-
der general anesthesia. The chest was reopened to expose the im-
planted AED through a median sternotomy. Hemodynamic
assessment, left atrial angiography, 2D EE, and Doppler echocardi-
ography were performed in the same manner as during the implant
surgery. After these procedures, the dogs were sacrificed under full
heparinization (500 U/kg) by rapid intravenous injection of sodium
pentobarbital (50 mg/kg) and potassium chloride (120 mEq).
Gross Necropsy and Histologic Evaluation
The totality of LAA exclusion and the response of the tissue sur-
rounding the AED were examined macroscopically. After the hearts
were harvested, the AED with the LAA and the surrounding left
atrium and left ventricular tissue were excised from the heart.
Both nitinol springs at the edge of the AED were cut off, and the
2 straight tubes with exterior urethane were pulled out of the fabric
covers that had adhered to the base of the LAA. A middle portion of
the entire LAA, perpendicular to the AED, with the polyester fabric
was taken for cross-sectioning. The cross-sectioned tissue samples
were fixed in 10% formalin for 48 hours and embedded in paraffin.
Sections were cut from each block at 4 mm and collected onto glass
slides. All sections were then dried for 60 minutes at 60C and
stained with hematoxylin-eosin. The connective tissue underneath
the AED and the LAA were assessed in cross-sections of the spec-
imens. The stapled RAA was also assessed in the same way as the
LAA. The stapled RAA was sliced perpendicularly to the staple
for cross-sectioning in a similar fashion.
Atrial Natriuretic Peptide and Brain Natriuretic
Peptide
The mean levels of atrial natriuretic peptide (ANP) and brain natri-
uretic peptide (BNP) were measured at the time of the implantation
and reassessed at 14 days or 30 days after implantation in 6 cases (5
cases in the 30-day study and 1 case in the 90-day study).
Data Analysis
All values are expressed as mean 6 standard deviation. Repeated-
measures analysis of variance trialswere used to assess the differences
among pre-LAA exclusion, post-LAA exclusion, and terminal study.
Results
Procedure for the Atrial Exclusion Device
Implantation
The AED was delivered easily on a beating heart in all dogs
(n5 14) in approximately 10 seconds without major compli-
cations or hemodynamic instability. In all cases, 2D EE,
Doppler echocardiography, and left atrial angiography re-
vealed no communication between the LAA and left atrium
and no blood flow in the LAA after implantation. Angiogra-The Journal of Thorphy of the left coronary artery showed patent LCX in all
cases. In 1 case of the 7-day study, the edge of the LAA
was torn when it was held with forceps to deploy the AED.
However, the LAA had been occluded with the AED, and
no additional suture was needed for the injured site because
the AED provided adequate compression forces to achieve
acute exclusion. All animals survived the implant study with-
out device-related complications, and their postoperative
courses were uneventful.
Procedure for Stapling the Right Atrial Appendage
The RAAwas stapled with the commercial apparatus. All sta-
pling was accomplished with ease. However, a small quantity
of blood oozed from the stapling in 3 of 4 early cases. All
cases with oozing eventually acquired hemostasis without
additional stitching, although the cases with oozing required
a few moments until complete hemostasis was obtained with
the assistance of manual compressing during the first few ex-
periments. In the latter cases of this series, we used fabric
sheets (Seamguard-Bioabsorbable: Gore and Associates
Inc, Flagstaff, Ariz) to stanch bleeding from the stapled
RAA. The 2D EE apparently showed no communication be-
tween the RAA and right atrium in all cases.
Hemodynamic, Echocardiographic, and
Angiographic Data
Hemodynamic and echocardiographic data are shown in Ta-
ble 1. There were no statistical differences among the studies
in reference to hemodynamics. There were no significant dif-
ferences in the 2D EE parameters, such as end-systolic left
atrial volume, EDV, ESV, stroke volume, and ejection frac-
tion. Doppler echocardiography and left atrial angiography
revealed no communication between the LAA and the left
atrial body and no blood flow in the LAA before the terminal
study. Left coronary angiography showed neither stenosis
nor obstruction after implantation (Figure 2).
Findings of the Left Atrial Appendage at the Terminal
Study
The AED remained at the base of the LAA without migration
in all cases. The AED did not affect adjacent structures, such
as the left atrial body, LCX, great cardiac vein, or pulmonary
artery. The AED demonstrated more pronounced adherence
to the surrounding tissues, especially the pericardium, in
the 90-day models than in the 30-day models. The AED
did not adhere to the wall of the main pulmonary artery in
any studies, but only to the fat surrounding the main pulmo-
nary artery. Likewise, the AED did not interfere with the
blood flow of the LCX or the great cardiac vein.
Examination of the Left Atrial Appendage at
Necropsy
All of the AEDs from the 30- and 90-day studies were com-
pletely covered with translucent fibrous tissue (Figure 3, A),acic and Cardiovascular Surgery c Volume 136, Number 4 1021
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Pre-LAA exclusion Post-LAA exclusion Terminal study P value
Hemodynamics
Heart rate (beats/min) 109 6 12 110 6 13 118 6 17 .076
SBP (mm Hg) 115 6 13 111 6 10 105 6 16 .129
DBP (mm Hg) 72 6 13 68 6 14 65 6 18 .429
Mean LAP (mm Hg) 9.8 6 4.3 10.6 6 4.4 8.4 6 3.2 .129
2D EE
End-systolic LAV (mL)b 17.9 6 4.8 13.9 6 2.8 17.3 6 5.3 .096
EDV (mL)a 63.6 6 17.9 59.4 6 16.4 55.5 6 12.4 .060
ESV (mL)a 36.4 6 15.0 35.1 6 14.7 32.1 6 12.0 .142
SV (mL)a 27.1 6 5.2 24.3 6 4.8 23.5 6 2.9 .160
EF (%)a 44.3 6 8.7 42.6 6 10.1 43.8 6 9.3 .342
LAA, Left atrial appendage; SBP, systolic blood pressure; DBP, diastolic blood pressure; LAP, left atrial pressure; 2D EE, 2-dimensional epicardial echocardi-
ography; LAV, left atrial volume; EDV, end-diastolic volume; ESV, end-systolic volume; SV, stroke volume; EF, ejection fraction.
No significant difference was found among each data point. aThese measurements were obtained from available data in 9 animals. bThese measurements
were obtained from available data in 7 animals.although the AED had not yet been covered with tissue in the
7-day study. The internal surface of the occluded orifice to
the LAA was straight and smooth in all of the studies (Fig-
ure 3, B). The orifice was covered with a white tissue. There
was neither laceration nor hemorrhage along the occlusion
line in any studies. No thrombus formation in the left atrium
was found in any studies. In the 30-day study, a fibrous tissue
had grown at the orifice to the LAA underneath the titanium
tubes. In the 90-day study, the fibrous tissue had grown so
firmly that the occluded appendage could not be detached
when either of the AED tubes was removed. Also, the fibrous
tissue could not be detached, even though it was pulled in the
opposite direction by hand. In AEDs from the 7-day study,
the fibrous tissue growth was still fragile. In regard to the oc-
cluded LAA, in the 90-day study the LAA had been com-
pletely organized and occupied by a well-organized
thrombus or dense fibrous tissue (Figure 3, A and C). In the
30-day study, the LAA had been atrophied and had orga-
nized. The 7-day study demonstrated many thrombi in the
still bulged LAA, although the LAA was completely oc-
cluded. In all studies (with the exception of that in which
the LAA had been injured during AED implantation), the
LAA showed no perforation.
Histologic Examinations of the Left Atrial Appendage
In all studies, the polyester fabric of the AED was infiltrated
by fibroblasts that produced fibrous collagen, which implied
a mild inflammatory reaction (Figure 4, A). In the 90-day
study, a thick layer of fibrous tissue underneath the AED
was found and the fibrous tissue was smoothly covered
with a new endothelial layer (Figure 4, B). Although the
30-day study demonstrated fibrous tissue and a new endothe-
lial layer, the fibrous connective tissue was less dense than
that found in sections from the 90-day study. In regard to1022 The Journal of Thoracic and Cardiovascular Surgery c Octhe wall of LAA occluded by the AED, myocardial tissue
of the atrophied LAA was replaced by fibrous tissue in
each 90-day study, whereas the LAA was replaced by fibrous
tissue in only three of five 30-day cases, whereas the rest of
the LAA had atrophied moderately. With regard to the 7-
day study, the myocardium of the LAA had been infiltrated
with fibroblasts.
Findings of the Right Atrial Appendage at the
Terminal Study
EE revealed that the stapled RAA had no flow signal in all
cases. The site at which the RAA had been stapled showed
neither a remarkable reaction nor any abnormal adhesion to
surrounding tissues. In half of the 90-day cases, bulging in
the RAA was noted (Figure 5, A). In five of six 30-day cases,
the RAA did not shrink, and there was some residual muscle
tissue. In the 7-day study, the RAA remained as it had been at
the implantation.
Examinations of the Right Atrial Appendage at
Necropsy
The staple did not have any abnormal adhesion or affect sur-
rounding organs, including the right ventricle or the right cor-
onary artery in all cases. The internal surface of the stapled
site also was found to be irregular because of the stapling
(Figure 5, B). A part of the stapled RAA wall became thin,
and the staple itself was seen from the right atrium (RA). A
new fibrous tissue observed in the LAA was not apparently
found on the stapled RA wall even in the 90-day study.
Some cases had small marks from intramural hemorrhages
present along the stapled line. No thrombus was found in
the right atrium, including on the stapled orifice to the
RAA. There were no lacerations along the stapled line in
any studies. The RAA cavity was totally occluded in alltober 2008
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cases from the 30-day study, and all 3 cases from the 7-day
study showed that the RAA cavity was not yet organized
and had bulged with noncoagulated blood. The other cases
had organized clot in the RAA.
Figure 2. Coronary angiogram of the LCX at the terminal study. No
adverse effects of the implanted AED (white arrows) on the LCX
were found in left anterior oblique 60-degree planes (A) or right
anterior oblique 30-degree planes (B). LCX, Left circumflex artery;
AED, atrial exclusion device (third generation).The Journal of ThoraHistologic Examinations of the Right Atrial
Appendage
The stapled sites did not yield a smooth fibrous tissue layer in
any cases. A fibrous tissue at the stapled site had calcium
deposition, which implies a severe inflammatory reaction
(Figure 6, A and B). The endothelial surface also showed ir-
regularities, and the endothelial surface did not resemble any
of the new layers found on the LAA in appearance. All of the
RAAs had not replaced the cardiac muscle with the fibrous
tissue completely even in 90-day cases. The cases of the
RAA that had not collapsed yet at the terminal study showed
no evidence that the RAA wall had been replaced with
fibrous tissue.
Atrial Natriuretic Peptide and Brain Natriuretic
Peptide
The mean levels of ANP at preimplantation and 14 and
30 days postimplantation were 32.0 6 20.4 pg/mL, 33.8 6
13.6 pg/mL, and 41.26 33.9 pg/mL, respectively. No signif-
icant differences were found among the data points. The level
of BNP at every point was less than 5 pg/dL in all cases.
Discussion
The third-generation AED successfully isolated the LAA
from the systemic circulatory system without any damage
to adjacent organs in all cases. The procedure to implant the
AED took approximately 10 seconds and did not affect hemo-
dynamic parameters, including EDV, ESV, stroke volume,
and ejection fraction. Fibrous tissue on the internal surface
of the occluded closure line without any severe inflammation
grew in response to the AED being implanted. The new endo-
thelial layer of the left atrial orifice occlusion, created by the
AED, was unique to only the LAA and not the RAA, which
had been stapled. AED application did not create an interface
between circulating blood and prosthetic material.
AF is the most common cardiac arrhythmia. The popula-
tion of patients with AF who are aged more than 40 years has
increased, and the population of patients with AF aged more
than 65 years is increasing exponentially.1,11 Currently, anti-
coagulation therapy reduces the risk of cardioembolic stroke
in patients with AF. Such anticoagulation therapy offers
many benefits, but there is also an increased risk associated
with management of warfarin dosages within desirable
ranges, as appropriate per age category.
A potential alternative therapy for stroke prevention in pa-
tients with AF is surgical exclusion of the LAA from the cir-
culatory system.5,7 Because thrombi commonly originate in
the LAA of patients with AF, surgical LAA occlusion theo-
retically decreases the rate of strokes. However, according
to the American College of Cardiology and American Heart
Association guidelines, LAA occlusion is recommended
only during mitral valve surgery.12 Several techniques, in-
cluding excision, ligation, suturing, or stapling for LAA ex-
clusion, have been performed during concomitant cardiaccic and Cardiovascular Surgery c Volume 136, Number 4 1023
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ETFigure 3. Representative macroscopic images of the LAA in 90-day
study. A, External surface of the left atrium. AED (black bar). The whole
AED is covered with fibrous tissue. The LAA is completely atrophied
(black arrows). B, Internal surface of the left atrium. The orifice of the
LAA (black arrows) is completely occluded. The occlusion line is clear
and smooth. Most of the occlusion line is filled with a white fibrous tis-
sue. C, Cross-section of the LAA occluded by the AED. The thrombus in
the LAA had already been organized. The polyester fabric is covered
with thin, clear, whitish tissue, and the LAA wall is smooth. Thick fi-
brous tissue is seen beneath the AED (white arrow). LCX (black arrow).
LA, Left atrium; AED, atrial exclusion device (third generation); LAA, left
atrial appendage.1024 The Journal of Thoracic and Cardiovascular Surgery c Osurgery, because these relevant procedures can be easily ac-
complished. On the other hand, some reports have revealed
that incomplete exclusion of the LAA after surgery actually
can increase the risk of stroke rather than prevent stroke.11,13
Although it seems easy to occlude the LAA with mere su-
turing, this standard surgical technique has been associated
with bleeding and incomplete exclusion. Also, as Su and col-
leagues14 have reported, the orifice of the LAA is not circular,
but rather oval. This suggests that the best way to close the
LAAmight be along the longitudinal diameter. If the direction
of LAA closure does not coincide with the longitudinal diam-
eter, or if sutures are distributed unevenly, there may be in-
creased risk of tissue tearing when the left atrium fills with
blood. As in suture closure or excision, stapled closure or ex-
cision can cause tearing and bleeding of the LAA. In this study,
staplingwas associatedwithminor bleeding and delayed endo-
thelial healing in comparison with AED implantation.
Figure 4. Representative microscopic images of the LAA in 90-day
study. A, Thick fibrous tissue is shown underneath the AED (mag-
nification 316). B, The fibrous tissue is smoothly covered with
a new endothelial layer (black arrows) (magnification 3100).
AED, Atrial exclusion device (third generation); LA, left atrium.ctober 2008
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ETFigure 5. Representative macroscopic images of the RAA in 90-
day study. A, External surface of the stapled right atrium. The
RAA had not collapsed yet. Black arrows indicate the stapled
line. B, Internal surface of the right atrium. The stapled orifice
of the RAA (black arrows) has indentation, although the orifice
is completely occluded. C, Cross-section of the occlusion site
by the stapler. The RAA was not completely atrophied, but it had
not been replaced with fibrous tissue yet. The thrombus in the
RAA had not been organized yet. RAA, right atrial appendage.The Journal of ThoraOur previous studies during the transitional stages of AED
development proposed the possibility of 2 issues. First, the
force at each point on the curved tubes may not be distributed
evenly when the AED with curved tubes opens widely in the
case of a particularly thick LAA, although we have not expe-
rienced any incomplete closure because of LAA thickness.
Second, the curved tubes of the second-generation AED
were designed so that the curved shape was supposed to
fit the shape of the LAA base. In previous studies, however,
the shape of the curved tubes made a small pit proximal to the
LAA occluded by the AED. No pits on the closed orifice that
were seen in the previous study were seen in the present
Figure 6. Representative microscopic images of the RAA in the 90-
day study. A, The stapled site (black arrow). Fibrous tissue was
found at the stapled site with calcium deposition, which implies
a pathologic reaction to what had been a locus of severe inflam-
mation (a purple spot on the stapled site) (magnification 316). B,
The internal surface of the stapled site (black arrows). A new
smooth endothelial layer that can be seen at the LAA occluded
by the AED has not been created (magnification 3100). LAA, Left
atrial appendage; AED, atrial exclusion device (third generation).cic and Cardiovascular Surgery c Volume 136, Number 4 1025
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more proximally to the left atrium than with the previously
curved AED. Donnino and colleagues15 have reported that
thrombus formation was found at the proximal portion of
the excluded LAA, although the distal LAA had been
excluded successfully, possibly because the LAAwas not ex-
cluded at the base of the LAA and the proximal portion was
still in contact with the circulation. This highlights the impor-
tance of more proximal LAA exclusion. In addition, firm fi-
brous tissue grew underneath the AED. The occlusion was
covered with a new endothelial layer in the 30- and 90-day
studies. The new endothelial layer of the occluded orifice
to the left atrium was found in both the present and previous
studies. In addition, the AED will be adapted for less-inva-
sive cardiac surgery in the future. The AED could be applied
on a beating heart via a small thoracoscopic incision or via
the subxyphoid approach if a delivery tool is developed for
minimally invasive surgery.
We compared RAA stapling with the AED. The stapling
caused bleeding from the targeted site.16,17 Also in the pres-
ent study, all cases except for those including fabric sheets to
reinforce the stapled sites required a few moments of com-
pression to stop bleeding, although no case needed to be su-
tured additionally to stop bleeding. However, the RAA was
totally occluded by stapling. The perforation of the wall by
staples caused severe inflammation, which was shown histo-
logically in the present study. The internal surface provided
by the stapling is indented, and the force to occlude the orifice
is not distributed evenly. The AED promoted organization of
the atrial wall and occluded appendage more rapidly, which
could be associated with evenly adequate distribution of
the pressure by the AED on the occluded closure line. In
addition, a new fibrous tissue observed in the LAA was not
apparently found on the stapled RA wall even in the 90-
day study. The diameter of the AED tubes is approximately
5 mm, which is larger than the diameter of the staple. The
large diameter of the AED provides greater contact area of
opposing atrial walls and shorter distances between opposing
atrial walls in the atrium proximal to the AED, which enables
the development of fibrous tissue. The fibrous tissue was not
observed at the proximal site of the stapled RAA. The fibrous
tissue in the LA was too thick to be detached by hand. There-
fore, the AED is thought to be superior to stapling. However,
we excluded the LAA by the AED and the RAA by the sta-
pler. It is a limitation of this study that there are fundamental
differences in left and right atrial tissue properties, anatomy,
and physiology. One limitation of the present study is that
there is no one-to-one comparison between stapling of the
LAA versus LAA occlusion by the AED.
The LAA is a potentially important structure, functioning
as an endocrine organ that releases ANP and BNP.18,19 ANP
is secreted by the atrium in response to atrial stretch, and the
ANP concentration is 40-fold higher in the LAA than in other
parts of the atrial wall or in the ventricles.18 Several investi-1026 The Journal of Thoracic and Cardiovascular Surgery c Ogators have demonstrated that the level of plasma ANP
decreased after bilateral atrial appendectomy in animal
models. In clinical settings, attenuation of ANP has been
found in patients after the maze procedure and bilateral atrial
appendectomy.20,21 This implies that amputation of both
atrial appendages could affect renal function. In the present
study, however, there was no significant attenuation of
ANP before or after bilateral atrial appendage occlusion.
No clinical signs of heart failure, including general fatigue
or significant changes in the animals’ weight, occurred. There
are 2 reasons why ANP levels did not diminish in the present
study. First, neither the LAA nor the RAA was resected,
which means that appendages were merely closed. Although
3 of the LAAs clipped by the AED were completely orga-
nized and replaced by fibrous tissue, the rest of the LAAs
and all RAAs were not completely organized yet. In addition,
we did not evaluate the levels of ANP under the condition of
loaded blood volume. If we had loaded the volume to the
animals, we would have found the influence from bilateral
atrial appendage exclusion. However, one limitation of the
present study is that only 6 animals were monitored for 30
days. The follow-up duration was not long enough; therefore,
more extensive evaluation must clarify the effect of bilateral
atrial appendage exclusion on ANP levels.
There are other limitations to this preclinical study. The
study series was small (n 5 14), and the follow-up period
was only a maximum of 90 days. It is possible that there
may be device failures or deployment complications with
a longer follow-up or with application in patients whose
tissues are less resilient than those of a healthy canine. In
addition, animals were in sinus rhythm rather than AF.
Conclusions
The third-generation AED achieved easy, reliable, and safe
exclusion of the LAA with favorable histologic results.
Clinical application may provide a new therapeutic option
for reducing the risk of stroke in patients with AF.
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